SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,171,725 | -8.3% | 42,500 | 0.0% | 0.06% | +31.2% |
| Q2 2023 | $1,277,550 | -17.0% | 42,500 | 0.0% | 0.05% | -15.8% |
| Q1 2023 | $1,539,775 | +1.6% | 42,500 | 0.0% | 0.06% | +7.5% |
| Q4 2022 | $1,515,975 | +36.1% | 42,500 | +29.2% | 0.05% | +20.5% |
| Q3 2022 | $1,114,000 | -97.6% | 32,900 | -98.9% | 0.04% | -94.6% |
| Q2 2022 | $46,562,000 | +4280.2% | 2,951,096 | +8869.9% | 0.82% | +2305.9% |
| Q1 2022 | $1,063,000 | +10.8% | 32,900 | 0.0% | 0.03% | +9.7% |
| Q4 2021 | $959,000 | +9.4% | 32,900 | 0.0% | 0.03% | +10.7% |
| Q3 2021 | $877,000 | -13.4% | 32,900 | 0.0% | 0.03% | -15.2% |
| Q2 2021 | $1,013,000 | – | 32,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |